329 related items for PubMed ID: 11730179
1. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB.
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
[Abstract] [Full Text] [Related]
2. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR.
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[Abstract] [Full Text] [Related]
3. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.
Nelson HS, Stricker W, Casale TB, Raff H, Fourré JA, Aron DC, Newman KB.
J Clin Pharmacol; 2002 Mar; 42(3):319-26. PubMed ID: 11865969
[Abstract] [Full Text] [Related]
4. Adrenal suppression with inhaled corticosteroids.
Lipworth BJ.
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):359-61. PubMed ID: 11730176
[No Abstract] [Full Text] [Related]
5. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
Corren J, Nelson H, Greos LS, Bensch G, Goldstein M, Wu J, Wang S, Newman K.
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
[Abstract] [Full Text] [Related]
6. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B, Faulds D.
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[Abstract] [Full Text] [Related]
7. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.
Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
[Abstract] [Full Text] [Related]
8. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L, Prietsch SO, Ducharme FM.
Cochrane Database Syst Rev; 2014 Jul 17; 2014(7):CD009471. PubMed ID: 25030198
[Abstract] [Full Text] [Related]
9. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
Nelson HS, Busse WW, deBoisblanc BP, Berger WE, Noonan MJ, Webb DR, Wolford JP, Mahajan PS, Hamedani AG, Shah T, Harding SM.
J Allergy Clin Immunol; 1999 Feb 17; 103(2 Pt 1):267-75. PubMed ID: 9949318
[Abstract] [Full Text] [Related]
10. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
Li JT, Goldstein MF, Gross GN, Noonan MJ, Weisberg S, Edwards L, Reed KD, Rogenes PR.
J Allergy Clin Immunol; 1999 Apr 17; 103(4):622-9. PubMed ID: 10200011
[Abstract] [Full Text] [Related]
11. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ, Lipworth BJ.
Thorax; 1997 Jan 17; 52(1):55-8. PubMed ID: 9039246
[Abstract] [Full Text] [Related]
12. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar 17; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
13. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW.
J Allergy Clin Immunol; 1998 Jul 17; 102(1):32-8. PubMed ID: 9679845
[Abstract] [Full Text] [Related]
14. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.
Ann Allergy Asthma Immunol; 2005 Apr 17; 94(4):465-72. PubMed ID: 15875528
[Abstract] [Full Text] [Related]
15. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM, Clark DJ, McFarlane L, Lipworth BJ.
Eur J Clin Pharmacol; 1997 Apr 17; 53(1):33-7. PubMed ID: 9349927
[Abstract] [Full Text] [Related]
16. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
Wilson AM, Lipworth BJ.
Br J Clin Pharmacol; 1999 Oct 17; 48(4):579-85. PubMed ID: 10583029
[Abstract] [Full Text] [Related]
17. Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate.
Niitsuma T, Okita M, Sakurai K, Morita S, Tsuyuguchi M, Matsumura Y, Hayashi T, Koshishi T, Oka K, Homma M.
J Asthma; 2003 Oct 17; 40(5):515-22. PubMed ID: 14529101
[Abstract] [Full Text] [Related]
18. Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults.
Brus R.
Arch Intern Med; 1999 Sep 13; 159(16):1903-8. PubMed ID: 10493320
[Abstract] [Full Text] [Related]
19. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Sheikh S, Goldsmith LJ, Howell L, Eid N.
Ann Allergy Asthma Immunol; 1999 Oct 13; 83(4):300-4. PubMed ID: 10541421
[Abstract] [Full Text] [Related]
20. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
Weiner P, Berar-Yanay N, Davidovich A, Magadle R.
Chest; 1999 Oct 13; 116(4):931-4. PubMed ID: 10531155
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
